Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RAY - VGG7385S1011 - Common Stock

1.65 USD
+0.07 (+4.43%)
Last: 12/19/2025, 8:12:05 PM
1.7399 USD
+0.09 (+5.45%)
After Hours: 12/19/2025, 8:12:05 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RAY. RAY was compared to 22 industry peers in the Distributors industry. RAY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. RAY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

RAY had positive earnings in the past year.
RAY had a positive operating cash flow in the past year.
Each year in the past 5 years RAY has been profitable.
In the past 5 years RAY always reported a positive cash flow from operatings.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.62%, RAY belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
With a decent Return On Equity value of 16.79%, RAY is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.76%, RAY is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for RAY is significantly above the industry average of 14.96%.
The last Return On Invested Capital (11.76%) for RAY is well below the 3 year average (21.00%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROIC 11.76%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 10.59%, RAY belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
In the last couple of years the Profit Margin of RAY has declined.
With an excellent Operating Margin value of 9.48%, RAY belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
RAY's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 22.10%, RAY is doing good in the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Gross Margin of RAY has declined.
Industry RankSector Rank
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RAY is creating value.
Compared to 1 year ago, RAY has more shares outstanding
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.36 indicates that RAY is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 4.36, RAY perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.36
ROIC/WACC1.21
WACC9.71%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

A Current Ratio of 5.29 indicates that RAY has no problem at all paying its short term obligations.
The Current ratio of RAY (5.29) is better than 90.91% of its industry peers.
A Quick Ratio of 5.19 indicates that RAY has no problem at all paying its short term obligations.
The Quick ratio of RAY (5.19) is better than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.19
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

4

3. Growth

3.1 Past

RAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.81%, which is quite good.
The Earnings Per Share has been decreasing by -4.13% on average over the past years.
The Revenue has grown by 22.00% in the past year. This is a very strong growth!
RAY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.41% yearly.
EPS 1Y (TTM)14.81%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-23.48%
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.09, which indicates a rather cheap valuation of RAY.
Based on the Price/Earnings ratio, RAY is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
RAY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.38.
Industry RankSector Rank
PE 1.09
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RAY indicates a rather cheap valuation: RAY is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.61
EV/EBITDA -4.44
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of RAY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

RAYTECH HOLDING LTD

NASDAQ:RAY (12/19/2025, 8:12:05 PM)

After market: 1.7399 +0.09 (+5.45%)

1.65

+0.07 (+4.43%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.09%
Inst Owner ChangeN/A
Ins Owners19.79%
Ins Owner ChangeN/A
Market Cap4.49M
Revenue(TTM)121.99M
Net Income(TTM)12.92M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.09
Fwd PE N/A
P/S 0.29
P/FCF 5.61
P/OCF 5.61
P/B 0.45
P/tB 0.45
EV/EBITDA -4.44
EPS(TTM)1.52
EY92.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY17.81%
OCF(TTM)0.29
OCFY17.81%
SpS5.76
BVpS3.64
TBVpS3.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.15
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROCE 15.03%
ROIC 11.76%
ROICexc N/A
ROICexgc N/A
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
FCFM 5.1%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 53.78%
Profit Quality 48.14%
Current Ratio 5.29
Quick Ratio 5.19
Altman-Z 4.36
F-Score4
WACC9.71%
ROIC/WACC1.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)14.81%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-23.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.86%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.5%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-60.5%
OCF growth 3Y-8.91%
OCF growth 5YN/A

RAYTECH HOLDING LTD / RAY FAQ

What is the fundamental rating for RAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to RAY.


What is the valuation status of RAYTECH HOLDING LTD (RAY) stock?

ChartMill assigns a valuation rating of 5 / 10 to RAYTECH HOLDING LTD (RAY). This can be considered as Fairly Valued.


Can you provide the profitability details for RAYTECH HOLDING LTD?

RAYTECH HOLDING LTD (RAY) has a profitability rating of 7 / 10.


How financially healthy is RAYTECH HOLDING LTD?

The financial health rating of RAYTECH HOLDING LTD (RAY) is 8 / 10.